Detalhe da pesquisa
1.
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(2): 223-234, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539742
2.
Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma-a long-term follow-up single center experience.
Ann Hematol
; 99(2): 265-276, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31897675
3.
Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial.
Br J Haematol
; 185(1): 42-52, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30592027
4.
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
Haematologica
; 104(6): 1202-1208, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573503
5.
Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
Lancet Oncol
; 18(12): 1680-1687, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29133014
6.
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 17(7): 928-942, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27216274
7.
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
Haematologica
; 105(5): 1465, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32358081
8.
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.
N Engl J Med
; 363(7): 640-52, 2010 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20818855
9.
FOLFIRI plus ramucirumab versus paclitaxel plus ramucirumab as second-line therapy for patients with advanced or metastatic gastroesophageal adenocarcinoma with or without prior docetaxel - results from the phase II RAMIRIS Study of the German Gastric Cancer Study Group at AIO.
Eur J Cancer
; 165: 48-57, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202974
10.
Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose Chemotherapy.
Cancers (Basel)
; 13(11)2021 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34071000
11.
Computed tomography texture analysis for assessment of chemotherapy response of Hodgkin lymphoma.
Medicine (Baltimore)
; 99(7): e19146, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32049838
12.
Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group.
J Clin Oncol
; 38(25): 2839-2848, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32574114
13.
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.
JAMA Oncol
; 6(6): 872-880, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32352505
14.
Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG).
Hemasphere
; 4(1): e336, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072150
15.
The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experience.
J Cancer Res Clin Oncol
; 145(10): 2595-2604, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31410605
16.
Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group.
Leukemia
; 36(2): 580-582, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34408266
17.
Size and attenuation CT (SACT) of residual masses in patients with follicular non-Hodgkin lymphoma: more than a status quo?
Eur J Radiol
; 81(7): 1657-61, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21459529
18.
Volume and attenuation computed tomography measurements for interim evaluation of Hodgkin and follicular lymphoma as an additional surrogate parameter for more confident response monitoring: a pilot study.
Cancer Imaging
; 11: 155-62, 2011 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22042236
19.
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial.
J Clin Oncol
; 28(13): 2239-45, 2010 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20368566
20.
[Systemic mastocytosis]. / Systemische Mastozytose.
Dtsch Med Wochenschr
; 130(9): 474, 2005 Mar 04.
Artigo
em Alemão
| MEDLINE | ID: mdl-15731964